Your shopping cart is currently empty

Heparin cofactor II precursor fragment [Homo sapiens] is a peptide with the sequence H2N-Tyr-Glu-Ile-Thr-Thr-Ile-His-Asn-Leu-Phe-Arg-OH, MW=1406.58.
![heparin cofactor II precursor fragment [Homo sapiens]](https://cdn.targetmol.com/group3/M00/02/B6/CgoaEGY7O6uEX42rAAAAAHkhfBc056.png)
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $50 | Inquiry | Inquiry | |
| 5 mg | $143 | Inquiry | Inquiry | |
| 10 mg | $235 | Inquiry | Inquiry | |
| 25 mg | $329 | Inquiry | Inquiry |
| Description | Heparin cofactor II precursor fragment [Homo sapiens] is a peptide with the sequence H2N-Tyr-Glu-Ile-Thr-Thr-Ile-His-Asn-Leu-Phe-Arg-OH, MW=1406.58. |
| In vitro | Heparin cofactor II(HCII) is a coagulation factor that inhibits IIa and is a cofactor for heparin and dermatan sulfate. The product encoded by this gene is a serine proteinase inhibitor which rapidly inhibits thrombin in the presence of dermatan sulfate or heparin. The gene contains five exons and four introns. This protein shares homology with antithrombin III and other members of the alpha 1-antitrypsin superfamily. Mutations in this gene are associated with heparin cofactor II deficiency. Heparin Cofactor II deficiency can lead to increased thrombin generation and a hypercoagulable state [1][2]. |
| Molecular Weight | 1406.58 |
| Formula | C65H99N17O18 |
| Smiles | O/C1=C/C=C(C=C1)C[C@@](N)([H])C(=O)N[C@@]([H])(CCC(O)=O)C(=O)N[C@]([H])(C(=O)N[C@]([H])(C(=O)N[C@]([H])(C(=O)N[C@]([H])(C(=O)N[C@@]([H])(CC=2NC=NC=2)C(=O)N[C@@]([H])(CC(N)=O)C(=O)N[C@@]([H])(CC(C)(C)[H])C(=O)N[C@@]([H])(C/C3=C/C=CC=C3)C(=O)N[C@@]([H])(CCCNC(N)=N)C(O)=O)[C@](C)([H])CC)[C@@](C)(O)[H])[C@](O)(C)[H])[C@](C)([H])CC |
| Relative Density. | no data available |
| Sequence | H-Tyr-Glu-Ile-Thr-Thr-Ile-His-Asn-Leu-Phe-Arg-OH |
| Sequence Short | YEITTIHNLFR |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: ≥140.7 mg/mL, Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.